Back to Journals » Drug Design, Development and Therapy » Volume 9

Cost-effectiveness analysis of lamivudine, telbivudine, and entecavir in treatment of chronic hepatitis B with adefovir dipivoxil resistance

Total article views   HTML views PDF downloads Totals
9,960 Dovepress* 8,766+ 1,642 10,408
PubMed Central* 1,194 408 1,602
Totals 9,960 2,050 12,010
*Since 2 June 2015
+Since July 2016
Total mentioned Facebook Delicious Reddit Twitter Others
4 0 0 0 2 2

View citations on PubMed Central and Google Scholar